Neuroleptic malignant syndrome.
dc.contributor.author | Bhattacharyya, K | en_US |
dc.date.accessioned | 1999-09-25 | en_US |
dc.date.accessioned | 2009-05-30T18:50:47Z | |
dc.date.available | 1999-09-25 | en_US |
dc.date.available | 2009-05-30T18:50:47Z | |
dc.date.issued | 1999-09-25 | en_US |
dc.identifier.citation | Bhattacharyya K. Neuroleptic malignant syndrome. Journal of the Association of Physicians of India. 1999 Sep; 47(9): 940 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/86222 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.japi.org | en_US |
dc.subject.mesh | Antipsychotic Agents --administration & dosage | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Neuroleptic Malignant Syndrome --diagnosis | en_US |
dc.subject.mesh | Risk Factors | en_US |
dc.subject.mesh | Schizophrenia --drug therapy | en_US |
dc.title | Neuroleptic malignant syndrome. | en_US |
dc.type | Comment | en_US |
dc.type | Letter | en_US |
Files
License bundle
1 - 1 of 1